What's new in IDIS/Web:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Black Box Warnings

 • Priority Clinical Practice Guidelines

 • Continuing Education Articles

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - May 2012

NEW DRUG TERM
AD-5-3-HTERT-CD-40-L
ALS-2-0426
AVAGACESTAT
BAY-60-5521
BRODALUMAB
CARMEGLIPTIN
CE-224535
DIPHT-TET-PERTUS-POLIO VACC
DNK-333
EMPAGLIFOZIN
FBS-0701
GEVOKIZUMAB
GSK-1521498
GSK-2118436
HM-30181
IFERANSERIN
NAGLIFLOZIN
PF-04457845
PLECANATI DE
PP-1420
PROMESTRIENE
R-1663
RIGOSERTIB
RO-4929097
ROSE-010
TAK-875
TENELIGLIPTIN

CODE
10121015
68200029
44100108
24060056
82000563
68200030
14000082
80120105
56220039
68200451
64000016
82000564
92000379
10121017
8180904
92000380
68200450
28081275
56120097
92250076
68160024
20120482
10121016
44100109
28081274
68200452
68200031


DRUG NAME/CODE CHANGES

OLD TERM & CODENEW TERM & CODE
LY-2439821 82000537IXEKIZUMAB 82000537
PF-734200 68200027GOSOGLIPTIN 68200027
TASOCITINIB 92000307TOFACITINIB 92000307


FDA APPROVAL PACKAGES

Article Numbers 674935-674949: Tafluprost, Zioptan, FDA Approval Package for NDA 202514. FDA Approval Package 2012.

Article Numbers 674920-674934: Glucarpidase, Voraxaze, FDA Approval Package for BLA 125327. FDA Approval Package 2012.

Article Numbers 674842-674855: Ivacaftor, Kalydeco, FDA Approval Package for NDA 203188. FDA Approval Package 2012.


ADVISORY COMMITTEE MEETINGS

Article Numbers 675895-675900: Anti-Infective Drugs Advisory Committee Meeting, April 4, 2012. FDA Advisory Committee 2012.

Article Numbers 675889-675894: Anti-Infective Drugs Advisory Committee Meeting, April 3, 2012. FDA Advisory Committee 2012.

Article Numbers 675883-675888: Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee, April 2, 2012. FDA Advisory Committee 2012.

Article Numbers 675878-675882: Endocrinologic and Metabolic Drugs Advisory Committee Meeting, March 28-29, 2012. FDA Advisory Committee 2012.

Article Numbers 675874-675877: Vaccines and Related Biological Products Advisory Committee Meeting, February 29, 2012. FDA Advisory Committee 2012.


BLACK BOX WARNINGS

Article Number 675873: Revised (2/15/2012): Ambrisentan: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 647184]. 2012.

Article Number 675872: Revised (3/26/2012): Itraconazole: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 615542]. 2012.

Article Number 675871: Revised (3/29/2012): Lisinopril: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 561111]. 2012.

Article Number 675870: Revised (1/19/2012): Telmisartan: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 559679]. 2012.

Article Number 675869: Revised (4/13/2012): Candesartan: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 556737]. 2012.

Article Number 675868: Revised (2/17/2012): Enalapril\Enalaprilat: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 557459]. 2012.

Article Number 675867: Revised (3/29/2012): Olmesartan: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 560808]. 2012.

Article Number 675866: Revised (4/16/2012): Aliskiren: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 628596]. 2012.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 675987: Holland S, Silberstein S D, Freitag F, Dodick D W, et al. Evidence-Based Guideline Update: NSAIDS and Other Complementary Treatments for Episodic Migraine Prevention in Adults: Report of the Quality Standards Subcommittee of American Academy of Neurology and American... (Ref Art 675986). Neurology 2012, 78:1346-1353.

Article Number 675986: Silberstein S D, Holland S, Freitag F, Dodick D W, et al. Evidence-Based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology & the American Headache Society (Ref Art 675987). Neurology 2012, 78:1337-1345.

Article Number 675862: Anonymous. Full Guideline. Infection: Prevention and Control of Healthcare-Associated Infections in Primary and Community Care. NICE Clinical Guideline No. 139 (Ref Art 675862-675864). NICE Clin Guidel 2012.

Article Number 675380: Fink H A, Ishani A, Taylor B C, Greer N L, et al. Screening For, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline (Ref Art 675381). Ann Intern Med 2012, 156:570-581.


CONTINUING EDUCATION ARTICLES

Article Number 676215: Anonymous. Ingenol Mebutate (Picato) for Acute Keratosis (0.1 CEU). Med Lett Drugs Ther 2012, 54:35-36.

Article Number 676214: Anonymous. Indacterol (Arcapta Neohaler) for COPD (0.1 CEU). Med Lett Drugs Ther 2012, 54:33-34.

Article Number 675770: Cada D J, Levien T L, Baker D E. Rivaroxaban in Nonvalvular Atrial Fibrillation (0.15 CEU). Hosp Pharm 2012, 47:293-320.

Article Number 675354: Anonymous. Drugs for Tuberculosis (0.2 CEU). Treat Guidel Med Lett 2012, 10:29-36.


College of Pharmacy